- Home
- ASRV vs RNTX Comparison
ASRV vs RNTX Comparison
Compare ASRV & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- RNTX
- Stock Information
- Founded
- ASRV 1983
- RNTX 2001
- Country
- ASRV United States
- RNTX United States
- Employees
- ASRV N/A
- RNTX N/A
- Industry
- ASRV Major Banks
- RNTX Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- RNTX Health Care
- Exchange
- ASRV Nasdaq
- RNTX Nasdaq
- Market Cap
- ASRV 51.0M
- RNTX 40.3M
- IPO Year
- ASRV N/A
- RNTX N/A
- Fundamental
- Price
- ASRV $2.80
- RNTX $1.27
- Analyst Decision
- ASRV
- RNTX
- Analyst Count
- ASRV 0
- RNTX 0
- Target Price
- ASRV N/A
- RNTX N/A
- AVG Volume (30 Days)
- ASRV 29.0K
- RNTX 32.4K
- Earning Date
- ASRV 07-22-2025
- RNTX 08-13-2025
- Dividend Yield
- ASRV 4.20%
- RNTX N/A
- EPS Growth
- ASRV N/A
- RNTX N/A
- EPS
- ASRV 0.22
- RNTX N/A
- Revenue
- ASRV $51,581,000.00
- RNTX N/A
- Revenue This Year
- ASRV N/A
- RNTX N/A
- Revenue Next Year
- ASRV N/A
- RNTX N/A
- P/E Ratio
- ASRV $12.88
- RNTX N/A
- Revenue Growth
- ASRV 13.95
- RNTX N/A
- 52 Week Low
- ASRV $2.03
- RNTX $1.25
- 52 Week High
- ASRV $3.42
- RNTX $4.40
- Technical
- Relative Strength Index (RSI)
- ASRV 36.74
- RNTX N/A
- Support Level
- ASRV $2.73
- RNTX N/A
- Resistance Level
- ASRV $2.99
- RNTX N/A
- Average True Range (ATR)
- ASRV 0.15
- RNTX 0.00
- MACD
- ASRV -0.05
- RNTX 0.00
- Stochastic Oscillator
- ASRV 11.86
- RNTX 0.00
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.